Immune-mediated diseases impact 1:7 people and are increasing in prevalence worldwide. They occur when the immune system mistakenly attacks the tissues of the body and can result in permanent organ damage or even death. Despite advances in treatment, many patients with immune-mediated diseases suffer from poor outcomes when their disease cannot be controlled with available therapies. At Climb Bio, we believe that we can impact the pathways that cause immune-mediated diseases to give patients precious time free of disease.
Company Details
- Employees
- 30
- Founded
- -
- Address
- Wellesley, Ma 02481, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://climbbio.com
- Keywords
- biotech, clinical development, Immunology.
- HQ
- Wellesley, MA
Climb Bio Questions
Climb Bio's website is http://climbbio.com
Climb Bio's LinkedIn profile is https://www.linkedin.com/company/climbbio
Climb Bio has
30 employees.
View email and phone details for 30
employees at Climb Bio.
Climb Bio's industry is
Biotechnology Research
Climb Bio's top competitors are
Nona Biosciences,
Incendia Therapeutics,
Spear Bio,
Vivtex,
Kytopen,
Triveni Bio,
Qld Biotherapeutics Inc,
Marengo Therapeutics,
Phast,
Pledge Therapeutics.
Climb Bio's categories are Biotechnology Research
Climb Bio's founding year is 2018
